Your browser doesn't support javascript.
loading
Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγnull mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products.
Kusakawa, Shinji; Machida, Kazuhiko; Yasuda, Satoshi; Takada, Nozomi; Kuroda, Takuya; Sawada, Rumi; Okura, Hanayuki; Tsutsumi, Hideki; Kawamata, Shin; Sato, Yoji.
Affiliation
  • Kusakawa S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Tokyo, Japan.
  • Machida K; Foundation for Biomedical Research and Innovation, Kobe, Japan.
  • Yasuda S; Testing Department, Central Institute for Experimental Animals, Kawasaki, Japan.
  • Takada N; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Tokyo, Japan.
  • Kuroda T; Foundation for Biomedical Research and Innovation, Kobe, Japan.
  • Sawada R; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Tokyo, Japan.
  • Okura H; Platform for Realization of Regenerative Medicine, Foundation for Biomedical Research and Innovation, Kobe, Japan.
  • Tsutsumi H; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Tokyo, Japan.
  • Kawamata S; Foundation for Biomedical Research and Innovation, Kobe, Japan.
  • Sato Y; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Tokyo, Japan.
Regen Ther ; 1: 30-37, 2015 Jun.
Article in En | MEDLINE | ID: mdl-31245439

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Regen Ther Year: 2015 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies Language: En Journal: Regen Ther Year: 2015 Document type: Article Affiliation country: Japan Country of publication: Netherlands